Epidemiology of prothrombin G20210A mutation in the mediterranean region

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 3, Issue 1, 2011, Pages

  Jadaon, Mehrez M ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875244450     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2011.054     Document Type: Article

References (110)

1. Dahlbäck B. Resistance to activated protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays. Pros and Cons. Thromb Haemost. 1995;73:739-742 PMid:7482395
2. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133-1134 http://dx.doi.org/10.1016/S0140-6736(95)91803-5
3. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of Factor V Leiden in 4047 men and women. Implications for venous thrmoboembolism screening. JAMA. 1997;277:1305-1307 http://dx.doi.org/10.1001/jama.277.16.1305
4. Zivelin A, Griffin JH, Xu X, Pabinger I, Samama M, Conard J, Brenner B, Eldor A, Seligsohn U. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood. 1997;89:397-402 PMid:9002940
5. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 1. Thromb Haemost. 1996;76:651-662 PMid:8950768
6. Davie EW. Biochemical and molecular aspects of the coagulation cascade. Thromb Haemost. 1995;74:1-6 PMid:8578439
7. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703 PMid:8916933
8. Ceelie H, Spaargaren-van Riel CC, Bertina RM, Vos HL. G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3'-end formation. J Thromb Haemost. 2004;2:119-127 http://dx.doi.org/10.1111/j.1538-2003.00493.x PMid:14717975
9. Meltzer ME, Lisman T, de Groot PG, Meijers JC, le Cessie S, Doggen CJ, Rosendaal FR. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood. 2010;116:113-121 http://dx.doi.org/10.1182/blood-2010-02-267740 PMid:20385790
10. Miljic P, Heylen E, Willemse J, Djordjevic V, Radojkovic D, Colovic M, Elezovic I, Hendriks D. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis. Srp Arh Celok Lek. 2010;138:74-78 PMid:20229688
11. Bertina, RM. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Cl Chem. 1997:43:1678-1683 PMid:9299960
12. Koeleman BPC, Reitsma PH, Bertina RM. Familial thrombophilia: a complex genetic disorder. Semin Hematol. 1997;34:256-264 PMid:9241710
13. Hillarp A, Zöller B, Svensson PJ, Dahlbäck B. The 20210A allele of the prothrombine gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost. 1997;78:990-992 PMid:9308741
14. Alhenc-Gelas M, Le Cam-Duchez V, Emmerich J, Frebourg T, Fiessinger JN, Barg JY, Aiach M. The A20210 allele of the prothrombin gene is not frequently associated with the factor V Arg506 to Gln mutation in thrombophilic families. Blood. 1997;96:1711
15. Dahlbäck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood. 2008;112:19-27 http://dx.doi.org/10.1182/blood-2008-01-077909 PMid:18574041
16. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998;79:706-708 PMid:9569177
17. Bykowska K, Vertun-Baranowska B, Windyga J, Lopaciuk S. Prevalence of G20210A prothrombin gene mutation in Poland. Pol Arch Med Wewn. 2000;104:729-733 PMid:11434083
18. McColl MD, Ellison J, Reid F, Tait RC, Walker ID, Greer IA. Prothrombin 20210 ?A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. BJOG. 2000;107:565-569 http://dx.doi.org/10.1111/j.1471-0528.2000.tb13281.x
19. Wramsby ML, Sten-Linder M, Bremme K. Primary habitual abortions are associated with high frequency of factor V Leiden mutation. Fertil Steril. 2000;74:987-991 http://dx.doi.org/10.1016/S0015-0282(00)01545-4
20. Vossen CY, Hoffmeister M, Chang-Claude JC, Rosendaal FR, Brenner H. Clotting factor gene polymorphisms and colorectal cancer risk. J Clin Oncol. 2011;29:1722-1727 http://dx.doi.org/10.1200/JCO.2010.31.8873 PMid:21422408
21. Petäjä J, Hiltunen L, Fellman V. Increased risk of intraventricular hemorrhage in preterm infants with thrombophilia. Pediatr Res. 2001;49:643-646 http://dx.doi.org/10.1203/00006450-200105000-00006
22. Avdonin PV, Kirienko AI, Kozhevnikova LM, Shostak NA, Babadaeva NM, Leont'ev SG, Petukhov EB, Kubatiev AA, Savel'ev VS. C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism. Ter Arkh. 2006;78:70-76
23. Lipay NV, Dmitriev VV, Borisenok MB. Thrombotic complications during cancer treatment in children. Exp Oncol. 2007;29:231-235 PMid:18004248
24. Keenan C, Livingstone WJ, White B, Mynett-Johnson L, Cusack S, Lawler M, Smith OP. Prevalence of the prothrombin G20210A mutation in the Irish populations: use of a novel polymerase chain reaction approach. Blood Coagul Fibrinolysis. 2000;11:669-672 PMid:7482395
25. Pherwani AD, Winter PC, McNamee PT, Patterson CC, Hill CM, Connolly JK, Maxwell AP. Is screening for factor V Leiden and prothrombin G20210A mutations in renal transplantation worthwhile? Results of a large single-center U.K. study. Transplantation. 2003;76:603-605
26. Jensen MK, de Nully Brown P, Thorsen S, Hasselbalch HC. Frequent occurrence of anticardiolipin antibodies, Factor V Leiden mutation, and perturbed endothelial function in chronic myeloproliferative disorders. Am J Hematol. 2002;69:185-191
27. Silingardi M, Salvarani C, Boiardi L, Accardo P, Iorio A, Olivieri I, Cantini F, Salvi F, La Corte R, Triolo G, Ciccia F, Ghirarduzzi A, Filippini D, Paolazzi G, Iori I. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum. 2004;51:177-183 PMid:9002940
28. Balogh I, Póka R, Losonczy G, Muszbek L. High frequency of factor V Leiden mutation and prothrombin 20210A variant in Romanies of Eastern Hungary. Thromb Haemost. 1999;82:1555-1556 PMid:8950768
29. Laczkovics C, Grafenhofer H, Kaider A, Quehenberger P, Simanek R, Mannhalter C, Lechner K, Pabinger I. Risk of recurrence after a first venous thromboembolic event in young women. Haematologica. 2007;92:1201-1207 PMid:8578439
30. Lalouschek W, Schillinger M, Hsieh K, Endler G, Tentschert S, Lang W, Cheng S, Mannhalter C. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke. 2005;36:1405-1409 PMid:8916933
31. Francès F, Portolès O, Gabriel F, Corella D, Sorlí JV, Sabater A, Alfonso JL, Guillén M. Factor V Leiden (G1691A) and prothrombin-G20210A alleles among patients with deep venous thrombosis and in the general population from Spain. Rev Med Chil. 2006;134:13-20 PMid:14717975
32. González Ordóñez AJ, Medina Rodríguez JM, Fernández Alvarez CR, Sánchez García J, Martín Sánchez L, Coto García E, Alvarez Martínez MV. 20210A mutation of the prothrombin and venous thromboembolism gene. Sangre (Barc). 1999;44:13-18 PMid:20385790
33. Alvarez A, Barroso A, Robledo M, Arranz E, Outeiriño J, Benítez J. Prevalence of Factor V Leiden and the G20210A mutation of the prothrombin gene in a random group of patients with thrombotic episodes. Sangre (Barc). 1999;44:7-12 PMid:20229688
34. Souto JC, Coll I, Llobet D, del Río E, Oliver A, Mateo J, Borrell M, Fontcuberta J. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost. 1998;80:366-369 PMid:9299960
35. Roldan V, Lecumberri R, Muñoz-Torrero JF, Vicente V, Rocha E, Brenner B, Monreal M; RIETE Investigators. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb Res. 2009;124:174-177 PMid:9241710
36. Leroyer C, Mercier B, Oger E, Chenu E, Abgrall JF, Férec C, Mottier D. Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost. 1998;80:49-51 PMid:9308741
37. Mazoyer E, Ripoll L, Gueguen R, Tiret L, Collet JP, dit Sollier CB, Roussi J, Drouet L; FITENAT Study Group. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution. Blood Coagul Fibrinolysis. 2009;20:503-510
38. Pasquier E, Bohec C, Mottier D, Jaffuel S, Mercier B, Férec C, Collet M, De Saint Martin L. Inherited thrombophilias and unexplained pregnancy loss: an incident case-control study. J Thromb Haemost. 2009;7:306-311 PMid:18574041
39. Reny JL, Alhenc-Gelas M, Fontana P, Bissery A, Julia PL, Fiessinger JN, Aiach M, Emmerich J. The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study. J Thromb Haemost. 2004;2:1334-1340 PMid:9569177
40. Martinelli I, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Mannucci PM. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. Br J Haematol. 2000;111:1223-1239 PMid:11434083
41. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, Bozzo M, Mannucci PM. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med. 2000;343:1015-1018
42. Margaglione M, Brancaccio V, De Lucia D, Martinelli I, Ciampa A, Grandone E, Di Minno G. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest. 2000;118:1405-411.
43. de Moerloose P, Reber G, Perrier A, Perneger T, Bounameaux H. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. Br J Haematol. 2000;110:125-129 PMid:21422408
44. Silingardi M, Salvarani C, Boiardi L, Accardo P, Iorio A, Olivieri I, Cantini F, Salvi F, La Corte R, Triolo G, Ciccia F, Ghirarduzzi A, Filippini D, Paolazzi G, Iori I. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum. 2004;51:177-183
45. Sottilotta G, Mammì C, Furlò G, Oriana V, Latella C, Trapani Lombardo V. High incidence of factor V Leiden and prothrombin G20210A in healthy southern Italians. Clin Appl Thromb Hemost. 2009;15:356-359
46. Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population. Thromb Haemost. 1999;82:1395-1398 PMid:18004248
47. Cattaneo M, Chantarangkul V, Taioli E, Santos JH, Tagliabue L. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels. Thromb Res. 1999;93:1-8
48. Bedencic M, Bozic M, Peternel P, Stegnar M. Major and potential prothrombotic genotypes in patients with venous thrombosis and in healthy subjects from Slovenia. Pathophysiol Haemost Thromb. 2008;36:58-63
49. Zerjavic K, Zagradisnik B, Stangler Herodez S, Lokar L, Glaser Krasevac M, Kokalj Vokac N. Is the JAK2 V617F mutation a hallmark for different forms of thrombosis? Acta Haematol. 2010;124:49-56
50. Jukic I, Bingulac-Popovic J, Dogic V, Babic I, Culej J, Tomicic M, Vuk T, Sarlija D, Balija M. ABO blood groups and genetic risk factors for thrombosis in Croatian population. Croat Med J. 2009;50:550-558
51. Herak DC, Antolic MR, Krleza JL, Pavic M, Dodig S, Duranovic V, Brkic AB, Zadro R. Inherited prothrombotic risk factors in children with stroke, transient ischemic attack, or migraine. Pediatrics. 2009;123:e653-660
52. Eterovic D, Titlic M, Culic V, Zadro R, Primorac D. Lower contribution of factor V Leiden or G202104 mutations to ischemic stroke in patients with clinical risk factors: pairmatched case-control study. Clin Appl Thromb Hemost. 2007;13:188-193
53. Coen D, Zadro R, Honovic L, Banfic L, Stavljenic Rukavina A. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism. Croat Med J. 2001;42:488-492
54. Kovac M, Mitic G, Mikovic Z, Djordjevic V, Savic O, Mandic V, Rakicevic LJ, Antonijevic N, Radojkovic D. Thrombophilia in women with pregnancy-associated complications: fetal loss and pregnancy-related venous thromboembolism. Gynecol Obstet Invest. 2010;69:233-238
55. Djordjevic V, Stankovic M, Brankovic-Sreckovic V, Rakicevic L, Radojkovic D. Genetic risk factors for arterial ischemic stroke in children: a possible MTHFR and eNOS gene-gene interplay? J Child Neurol. 2009;24:823-827
56. Djordjevic V, Rakicevic LJ, Mikovic D, Kovac M, Miljic P, Radojkovic D, Savic A. Prevalence of factor V leiden, factor V cambridge, factor II G20210A and methylenetetrahydrofolate reductase C677T mutations in healthy and thrombophilic Serbian populations. Acta Haematol. 2004;112:227-229
57. Foka ZJ, Lambropoulos AF, Makris PE, Constantinidis TC, Kotsis A. High frequency of factor V Leiden and prothrombin G20210A mutations in Greek hemophiliacs. J Thromb Haemost. 2003;1:1116-1167
58. Hatzaki A, Anagnostopoulou E, Metaxa-Mariatou V, Melissinos C, Philalithis P, Iliadis K, Kontaxis A, Liberatos K, Pangratis N, Nasioulas G. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients. Int Angiol. 2003;22:79-82 PMid:7482395
59. Zalavras ChG, Giotopoulou S, Dokou E, Mitsis M, Ioannou HV, Tsaousi C, Tzolou A, Kolaitis N, Vartholomatos G. Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism. Int Angiol. 2003;22:55-57
60. Agorastos T, Karavida A, Lambropoulos A, Constantinidis T, Tzitzimikas S, Chrisafi S, Saravelos H, Vavilis D, Kotsis A, Bontis J. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. J Matern Fetal Neonatal Med. 2002;12:267-273
61. Antoniadi T, Hatzis T, Kroupis C, Economou-Petersen E, Petersen MB. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol. 1999;61:265-267 PMid:9002940
62. Tug E, Aydin H, Kaplan E, Dogruer D. Frequency of genetic mutations associated with thromboembolism in the Western Black Sea Region. Intern Med. 2011;50:17-21 PMid:8950768
63. Altinisik J, Ates O, Ulutin T, Cengiz M, Buyru N. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients. Clin Appl Thromb Hemost. 2008;14:415-420 PMid:8578439
64. Irdem A, Devecioglu C, Batun S, Soker M, Sucakli IA. Prevalence of factor V Leiden and prothrombin G20210A gene mutation. Saudi Med J. 2005;26:580-583 PMid:8916933
65. Gurgey A, Haznedaroglu IC, Egesel T, Buyukasik Y, Ozcebe OI, Sayinalp N, Dundar SV, Bayraktar Y. Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis. Am J Hematol. 2001;67:107-111 PMid:14717975
66. Xenophontos SL, Hadjivassiliou M, Ayrton N, Karagrigoriou A, Pantzaris M, Nicolaides AN, Cariolou MA. Spectrum and prevalence of prothrombotic single nucleotide polymorphism profiles in the Greek Cypriot population. Int Angiol. 2002;21:322-329 PMid:20385790
67. Angelopoulou K, Nicolaides A, Constantinou Deltas C. Prevalence of genetic mutations that predispose to thrombophilia in a Greek Cypriot population. Clin Appl Thromb Hemost. 2000;6:104-107 PMid:20229688
68. Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Prevalence of prothrombin G20210 A, factor V G1691 A (Leiden), and methyltetrahydrofolate reductase (MTHFR) C 677T in seven different populations determined by multiple allele-specific PCR. Thromb Haemost. 1999;81:733-738 PMid:9299960
69. Dowling NF, Austin H, Dilley A, Whitsett C, Evatt BL, Hooper WC. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J Thromb Haemost. 2003;1:80-87 PMid:9241710
70. Tang Y, Sampson B, Pack S, Shah K, Yon Um S, Wang D, Wang T, Prinz M. Ethnic differences in out-of-hospital fatal pulmonary embolism. Circulation. 2011;123:2219-2225 PMid:9308741
71. Zakai NA, McClure LA. Racial Differences in Venous Thromboembolism. J Thromb Haemost. 2011; http://dx.doi.org/10.1111/j.1538-7836.2011.04443.x
72. Franco RF, Santos SE, Elion J, Tavella MH, Zago MA. Prevalence of the G20210A polymorphism in the 3'-untranslated region of the prothrombin gene in different human populations. Acta Haematol. 1998;100:9-12 PMid:18574041
73. Gibson CS, MacLennan AH, Rudzki Z, Hague WM, Haan EA, Sharpe P, Priest K, Chan A, Dekker GA; South Australian Cerebral Palsy Research Group. The prevalence of inherited thrombophilias in a Caucasian Australian population. Pathology. 2005;37:160-163 PMid:9569177
74. Zoossmann-Diskin A, Gazit E, Peleg L, Shohat M, Turner D. Thrombophilic polymorphisms in Israel. Blood Cells Mol Dis. 2008;41:230-233 PMid:11434083
75. Rees DC, Chapman NH, Webster MT, Guerreiro JF, Rochette J, Clegg JB. Born to clot: the European burden. Br J Haematol. 1999;105:564-566
76. Dilley A, Austin H, Hooper WC, El-Jamil M, Whitsett C, Wenger NK, Benson J, Evatt B. Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. J Lab Clin Med. 1998;132:452-455
77. Mack R, Chowdary D, Streck D, Dermody J. Inherited thrombophilia genes in minorities. Genet Test. 1999;3:371-373 PMid:21422408
78. Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, Ramírez-Cisneros FJ. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos. Am J Hematol. 2001;66:28-31
79. Ruiz-Argüelles GJ, López-Martínez B, Valdés-Tapia P, Gómez-Rangel JD, Reyes-Núñez V, Garcés-Eisele J. Primary thrombophilia in Mexico. V. A comprehensive prospective study indicates that most cases are multifactorial. Am J Hematol. 2005;78:21-26
80. Jun ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol. 2006;28:111-116 PMid:18004248
81. Lu Y, Zhao Y, Liu G, Wang X, Liu Z, Chen B, Hui R. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res. 2002 1;106:7-12
82. Sakuma M, Shirato K. The epidemiology of acute pulmonary thromboembolism. Nihon Rinsho. 2003;61:1706-1712
83. Miyata T, Kawasaki T, Fujimura H, Uchida K, Tsushima M, Kato H. The prothrombin gene G20210A mutation is not found among Japanese patients with deep vein thrombosis and healthy individuals. Blood Coagul Fibrinolysis. 1998;9:451-452
84. Chang JD, Hur M, Lee SS, Yoo JH, Lee KM. Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population. Clin Orthop Relat Res. 2008;466:1041-1046
85. Kim YH, Kim JS. The 2007 John Charnley Award. Factors leading to low prevalence of DVT and pulmonary embolism after THA: analysis of genetic and prothrombotic factors. Clin Orthop Relat Res. 2007;465:33-39
86. Shen MC, Lin JS, Tsay W. Protein C and protein S deficiencies are the most important risk factors associated with thrombosis in Chinese venous thrombophilic patients in Taiwan. Thromb Res. 2000;99:447-452
87. Lin JS, Shen MC, Tsay W. The mutation at position 20210 in the 3'-untranslated region of the prothrombin gene is extremely rare in Taiwanese Chinese patients with venous thrombophilia. Thromb Haemost. 1998;80:343
88. Newton LJ, Krishnan A, Parapia LA. Born to clot: the European burden. Br J Haematol. 1999;107:213
89. Kumar SI, Kumar A, Srivastava S, Saraswat VA, Aggarwal R. Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case-control study. Indian J Gastroenterol. 2005;24:211-215 PMid:16361766
90. Ghosh K, Shetty S, Madkaikar M, Pawar A, Nair S, Khare A, Pathare A, Jijina F, Mohanty D. Venous thromboembolism in young patients from western India: a study. Clin Appl Thromb Hemost. 2001;7:158-165 http://dx.doi.org/10.1177/107602960100700214 PMid:11292195
91. Angeline T, Bentley HA, Hawk AB, Manners RJ, Mokashi HA, Jeyaraj N, Tsongalis GJ. Prevalence of the Factor V G1691A and the Factor II/prothrombin G20210A gene polymorphisms among Tamilians. Exp Mol Pathol. 2005;79:9-13 http://dx.doi.org/10.1016/j.yexmp.2005.03.003 PMid:15896772
92. Garewal G, Das R, Ahluwalia J, Mittal N, Varma S. Prothrombin G20210A is not prevalent in North India. J Thromb Haemost. 2003;1:2253-2254 http://dx.doi.org/10.1046/j.1538-7836.2003.00430.x PMid:14521619
93. Bennett JA, Palmer LJ, Musk AW, Erber WN. Prevalence of factor V Leiden and prothrombin 20210A mutations in indigenous Australians. Thromb Haemost. 2001;86:1592-1593 PMid:11776339
94. Tamim H, Finan RR, Almawi WY. Prevalence of two thrombophilia predisposing mutations: factor V G1691A (R506Q; Leiden) and prothrombin G20210A, among healthy Lebanese. Thromb Haemost. 2002;.88:691-692
95. Finan RR, Tamin H, Amen G, Sharide HE, Rasid M, Alunen WY. Factor V G1691A and factor II G20210A mutations. Am J Hematol. 2002;71:300-305 http://dx.doi.org/10.1002/ajh.10223 PMid:12447960
96. Sabbagh AS, Ibrahim G, Kanaan Z, Shammaa DM, Khalek RA, Ghasham M, Greige L, Mahfouz RA. Prevalence of the prothrombin G20210A polymorphism in the Lebanese population: use of a reverse hybridization strip assay approach. Mol Biol Rep. 2009;36:399-403 http://dx.doi.org/10.1007/s11033-007-9193-0 PMid:18066679
97. Bouaziz-Borgi L, Almawi WY, Mtiraoui N, Nsiri B, Keleshian SH, Kreidy R, Louzir B, Hezard N, Mahjoub T. Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon. Am J Hematol. 2006;81:641-643 http://dx.doi.org/10.1002/ajh.20582 PMid:16823828
98. Almawi WY, Keleshian SH, Borgi L, Fawaz NA, Abboud N, Mtiraoui N, Mahjoub T. Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs. J Thromb Thrombolysis. 2005;20:163-168 http://dx.doi.org/10.1007/s11239-005-3550-4 PMid:16261289
99. Ameen G, Irani-Hakime N, Fawaz NA, Mahjoub T, Almawi WY. An Arab selective gradient in the distribution of factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T. J Thromb Haemost. 2005;3:2126-2127 http://dx.doi.org/10.1111/j.1538-7836.2005.01546.x PMid:16102131
100. Dagan E, Brik R, Broza Y, Gershoni-Baruch R. Henoch-Schonlein purpura: polymorphisms in thrombophilia genes. Pediatr Nephrol. 2006;21:1117-1121 http://dx.doi.org/10.1007/s00467-006-0155-x PMid:16791607
101. Attia FM, Mikhailidis DP, Reffat SA. Prothrombin Gene G20210A Mutation in Acute Deep Venous Thrombosis Patients with Poor Response to Warfarin Therapy. Open Cardiovasc Med J. 2009;3:147-151 http://dx.doi.org/10.2174/1874192400903010147 PMid:19920886 PMCid:2778014
102. Mahjoub T, Mtiraoui N, Tamim H, Hizem S, Finan RR, Nsiri B, Almawi WY. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages. Am J Hematol. 2005;80:12-19 http://dx.doi.org/10.1002/ajh.20419 PMid:16138341
103. Mtiraoui N, Borgi L, Hizem S, Nsiri B, Finan RR, Gris JC, Almawi WY, Mahjoub T. Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol. 2005;119:164-170 http://dx.doi.org/10.1016/j.ejogrb.2004.07.003
104. Frere C, Saut N, Boukef MK, Zili M, Toumi NE. Factor V Leiden G1691A and prothrombin G20210A mutations are common in Tunisia. J Thromb Haemost. 2003;1:2451-2452 http://dx.doi.org/10.1046/j.1538-7836.2003.0468b.x PMid:14629484
105. Klai S, Fekih-Mrissa N, Rachdi R, Gritli N. The status of thrombophilic defects and non-O blood group as risk factors for gestational vascular complications among Tunisian women. Acta Haematol. 2011;125:115-120 http://dx.doi.org/10.1159/000321934 PMid:21109732
106. Helley D, Chafa O, Yaker NL, Reghis A, Fischer AM. Prevalence of the prothrombin gene 20210A mutation in thrombophilic and healthy Algerian subjects. Thromb Haemost. 1999;82:1554-1555 PMid:10595654
107. Mathonnet F, Nadifi S, Serazin-Leroy V, Dakouane M, Giudicelli Y. Absence of factor V Leiden mutation and low prothrombin G 20210 A mutation prevalence in a healthy Moroccan population. Thromb Haemost. 2002;88:1073-1074 PMid:12529766
108. They-They TP, Hamzi K, Moutawafik MT, Bellayou H, El Messal M, Nadifi S. Prevalence of angiotensin-converting enzyme, methylenetetrahydrofolate reductase, Factor V Leiden, prothrombin and apolipoprotein E gene polymorphisms in Morocco. Ann Hum Biol. 2010;37:767-777 http://dx.doi.org/10.3109/03014461003738850 PMid:20687780
109. They-They TP, Battas O, Slassi I, Rafai MA, Katumbay DT, Nadifi S. Prothrombin G20210A and Factor V Leiden Polymorphisms in Stroke. J Mol Neurosci. 2011 [accepted for publication] http://dx.doi.org/10.1007/s12031-011-9580-9 PMid:21701789
110. Zivelin A, Rosenberg N, Faier S, Kornbrot N, Peretz H, Mannhalter C, Horellou MH, Seligsohn U. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood. 1998, 92(4):1119-24. PMid:9694698